Heme iron polypeptide in treatment of anemia inpregnancy

Journal Title: Obs Gyne Review: Journal of Obstetric and Gynecology - Year 2018, Vol 4, Issue 3

Abstract

Introduction: Treatment of iron deficiency anemia with non-heme iron salts still remains a challenge. The negative influence of various dietary elements and medications slows the absorption of iron from iron salts which makes it less bio-available, the side effects associated with iron salts, results in poor compliance. But Heme Iron Polypeptide claims to overcome the short comings of the non – heme oral iron. Materials and Methods: This prospective clinical study was done on patients of SSG Hospital, Baroda; 100 mild to moderate anemia pregnant patients between 16 to 28 weeks were included. The primary outcome of interest was mean maternal hemoglobin and serum ferritin levels at the end of treatment. Secondary outcomes were treatment related side effects and compliance. Results: There was significant rise in hemoglobin [mean difference (MD), 1.05841; p< 0.001] and serum ferritin [mean difference (MD) 7.3715, p, 0.001]. No side effects and good compliance with Heme Iron Polypeptide. Conclusion: Heme Iron Polypeptide is promising supplementary treatment for iron deficiency anemia in pregnancy as there was significant rise in hemoglobin and other iron indices which are comparable to oral iron salts. Heme Iron Polypeptide is a better source of iron for iron deficiency anemia in pregnancy, as it has less side effects especially gastrointestinal side effects, because of which it has better compliance.

Authors and Affiliations

Shonali Agrawal, Shruthi Alevoor

Keywords

Related Articles

A prospective study of morbidity patterns in ectopic pregnancy at a tertiary care hospital

Introduction: Ectopic pregnancy is potentially life-threatening and remains the leading cause of maternal death. The incidence of ectopic pregnancy is increased during last few years all over the world. Objective: To stu...

Cutaneous manifestation in pregnancy

Back ground: During pregnancy there is immunologic, metabolic, endocrine and vascular changes responsible for physiological and pathological skin changes. Aims and Objectives: The objectives of the study to determine the...

Serum 25- hydroxy vitamin D levels in pregnant women with increase in parity in Tamilnadu population

Introduction: Prevalence of vitamin D deficiency among pregnant women is a preventable and treatable health problem. Studies on vitamin D deficiency in pregnant women reported the adverse effects on maternal health and f...

Comparative study of different routes of hysterectomy

Background: To compare the various routes of hysterectomy and find the most commonly performed hysterectomy type and the various complications associated with each. Methods: This prospective study was carried out in the...

Evaluation of Endometrium in Postmenopausal bleeding women

Background: Postmenopausal bleeding (PMB) is one of the most frequent reasons for referral to gynecologist Objective: To investigate the clinical implication and endometrial pathological changes in patients with postmeno...

Download PDF file
  • EP ID EP497823
  • DOI 10.17511/jobg.2018.i3.03
  • Views 180
  • Downloads 0

How To Cite

Shonali Agrawal, Shruthi Alevoor (2018). Heme iron polypeptide in treatment of anemia inpregnancy. Obs Gyne Review: Journal of Obstetric and Gynecology, 4(3), 55-61. https://europub.co.uk/articles/-A-497823